The history of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in revenue , its patent expiration created a wave of generic competition , significantly eroding its dominance. While certain firms may attempt to knockoff capitalize on male sexual dysfunction,